Study Evaluating IMA-638 in Asthma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2006

Study Completion Date

April 30, 2007

Conditions
Asthma
Interventions
DRUG

IMA-638

Trial Locations (1)

80230

Denver

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00339872 - Study Evaluating IMA-638 in Asthma | Biotech Hunter | Biotech Hunter